trending Market Intelligence /marketintelligence/en/news-insights/trending/Cr1xNEZnz3WSYmMUsNlneA2 content esgSubNav
In This List

Jaguar Animal Health to distribute foal product via Henry Schein

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Jaguar Animal Health to distribute foal product via Henry Schein

Henry Schein Inc. secured the rights to distribute Jaguar Animal Health Inc.'s Neonorm foal product in the U.S. equine market.

Henry Schein will be responsible for obtaining regulatory approvals to market and distribute the anti-diarrheal product for foals.

The agreement will run for an initial one-year period that started Dec. 9; it will renew automatically unless canceled.